Clinical Trial Update: Octreotide VS Placebo in Prevention of Salivary Fistulae After Post Radiation Salvage Surgery [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating octreotide versus placebo to prevent salivary fistulae after post-radiation salvage surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fistula
• Salivary Duct or Gland

Drugs mentioned

• OCTREOTIDE (OCTREOTIDE ACETATE)

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Fistula; Salivary Duct or Gland | Phase 2 | Status: UNKNOWN